Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us    
Stock Report

| More

DIL Limited announces Q4 financial results

Posted On: 2018-05-16 10:28:45

DIL Limited has announced the Consolidated financial results for the year ended March 31, 2018.

FY18 Consolidated Performance:

- Total Revenue at Rs. 311.92 Cr. growth of 85% YoY
- EBITDA Rs. 101.96 Cr. (32.68% of Revenues), YoY growth of ~592%
- PAT before share of profit/(loss) of associates and joint-venture and non-controlling interests Rs. 54.83 Cr as against Negative Rs. 8.23 Cr the previous year

- Board of Directors proposed final equity dividend of Rs. 2.50 per share (Face Value Rs. 10), based on DIL's standalone annual financial statement

Fermenta Biotech Limited, 91.2% Subsidiary of DIL Limited

Fermenta Biotech Limited (FBL) manufactures Vitamin D3 (Cholecalciferol), the only manufacturer and supplier in India and amongst the top few global manufacturers. Apart from Vitamin D3, it also manufactures niche APIs', and is a major supplier of Penicillin G Amidase, Polymer Supports and enzyme technologies for beta lactams and Bio-Enzymes for Environmental Solutions.

- Revenues of Rs. 300.48 Cr for FY18 as against Rs. 163.12 Cr in FY17, up by 84% YoY. Growth in revenues attributable to increased volumes of Vitamin D3 and higher price realization from sales of Vitamin D3 Feed Grade Powder

- EBITDA Rs. 103.18 Cr (34.34% of revenues) for FY18 as against Rs. 22.97 Cr. (14.08% of revenues) in FY17

- PAT of Rs. 72.06 Cr in FY 18 as against Rs. 10.34 Cr in FY 17; growth of 596.9% YoY

Commenting on the performance Mr. Satish Varma, Managing Director, Fermenta Biotech Limited said, "As a leading player in the Vitamins industry, we are pleased with our increased market share in the global Vitamin D3 market. Our investment over the last few years in our manufacturing capacities and focus on quality has helped the Company continuously expand its footprint globally and meet the increasing demand for Vitamin D3.

With the many essential benefits of Vitamin D3 and its role in most of the body's vital processes becoming more and more recognized and accepted, we are confident of our continued growth in the coming years in both the domestic as well as international markets. Our continued focus on manufacturing quality products complemented with in-house R&D, will help us maintain our established position in this growing market."

DIL holds 91.2% equity stake in Fermenta Biotech Limited (FBL), which was incorporated in 1986.

FBL is engaged in manufacturing of Vitamin D3, other specialty API's, biological enzymes and also offers integrated biotech based environmental solutions. FBL has 2 manufacturing facilities:

- Kullu in Himachal Pradesh - cGMP certified and currently manufactures vitamin D3, specialty API's and Enzymes

- Dahej SEZ - set up in 2011 and manufactures Vitamin D3

DIL has developed premium office spaces named 'THANE ONE', with a total leasable area of 200,000 sq. ft., which is currently about 95% occupied.

Shares of DIL LTD. was last trading in BSE at Rs.3667.25 as compared to the previous close of Rs. 3694.95. The total number of shares traded during the day was 3940 in over 236 trades.

The stock hit an intraday high of Rs. 3794.8 and intraday low of 3650. The net turnover during the day was Rs. 14629093.

Source: Equity Bulls

Click here to send ur comments or to

Other Headlines:

Strides Vivimed JV receives approval for Albendazole Tablets

Wipro Digital to expand Asia Pacific design capabilities in Australia

KDDL Ltd to acquire Estima AG

Anka India Ltd updates on warrants

Cox & Kings Ltd updates on sale of Education Division by subsidiary

GMR Infra subsidiary raises Rs. 2256 million through CCDs

Ganesh Films India Ltd acquires distribution rights of few upcoming tamil movies

Lupin receives tentative US FDA approval for Apixaban Tablets, 2.5 mg and 5 mg

Zensar selected as IT Infrastructure partner by EBRD, UK

Titagarh Wagons Ltd bags contract to supply 5058 wagons to Indian Railways

Scooters India Ltd calls for board meeting on Dec 14, 2018

TCS Wins Association for Talent Development's 2018 BEST Award

Garnet International Ltd receives RBI nod for non-deposit taking NBFI

AEGON signs new five-year IT transformation deal with HCL

TCM Ltd announces resignation of Executive Director

Lupin's Pithampur Unit-3, Indore receives EIR from US FDA

Thomas Cook India Ltd opens new office in Vesu, Surat

Maestros Electronics & Telecommunications Systems Ltd to consider warrants issue

Container Corporation of India Ltd board to consider bonus issue on Dec 20, 2018

Escorts and Kubota join hands for Global Leadership

Tata Motors Group global wholesales at 1,04,964 in November 2018

Elecon Engineering Company Limited to consider NCD issue upto Rs. 150 crores

Nestle India launches Nestle EVERYDAY Chai Life

Maruti Suzuki achieves five lakh cumulative CNG vehicle sales

RITES Ltd board to consider interim dividend on Dec 17, 2018

Cravatex Limited announces demise of Non-executive Director

Alembic Pharmaceuticals receives USFDA Approval for Ophthalmic Solution

Oriental Veneer Products Ltd arm secures contract worth Rs. 152.31 crores

Seamec Ltd enters into charter hire of vessel at Mumbai High Offshore

Landmarc Leisure Corporation Ltd update on upcoming Marathi film 'Nashibvaan'

Dharamsi Morarji Chemical Company Ltd fixes Dec 21, 2018 as record date for Interim Dividend

OK Play India Ltd announces resignation of CFO

Ansal Properties & Infrastructure Ltd announces resignation of Mr. Bihari Lal Khurana

AXIS Bank Ltd appoints Shri Amitabh Chaudhry as MD and CEO

Seamec Ltd's vessel concludes charter hire with Aqua Omega Services Pvt. Ltd.

Ashoka Buildcon Ltd receives LOA from Rail Vikas Nigam Limited

Pritish Nandy Communications Ltd announces its Amazon Original launch

Alembic Pharmaceuticals Ltd to consider allotment of NCDs upto Rs. 350 crores

Mangalam Drugs & Organics Ltd receives WHO pre-qualification approval for Unit-1

United Breweries Ltd announces resignation of CFO from Jan 1, 2019

Dharamsi Morarji Chemical Company Ltd declares interim dividend of Rs. 0.50 on Equity Shares

Dilip Buildcon Ltd receives LOA for project worth Rs. 1000.36 crores

CRISIL revises rating of Man Industries India Ltd

Jaguar Land Rover posts strong growth in North America

L&T Construction wins orders valued Rs.2,547 Crore

Gujarat Alkalies and Chemicals Ltd approves expansion of Caustic Soda Plant at Dahej

AstraZeneca Pharma India Ltd and Abbott enter into distribution agreement for Dapagliflozin

Atishay Limited receives order for Voter ID card in Maharashtra

Techno Electric & Engineering Company Ltd receives orders of Rs. 313 crores

HCL Technologies to acquire select IBM Software Products for $1.8bn

Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2018